SCHEMBL8224090

SCHEMBL8224090

Cc1ccc(C2(c3cccc(Br)c3)NC(=S)N3CCCN=C32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 12/20 0.44
CTSD P07339 4/20 0.44
BACE2 Q9Y5Z0 6/20 0.36
APP P05067 1/20 0.36
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
SLC6A4 P31645 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
HDAC8 Q9BY41 4/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8217676 0.94 BACE1 (0.37) BACE1CTSDCHRNA1CHRNGCHRNB1
SCHEMBL4883509 0.91 BACE1 (0.45) BACE1CTSDBACE2APPHDAC8
SCHEMBL4887798 0.89 BACE1 (0.44) BACE1CTSDBACE2APPCHRNA1
SCHEMBL4883711 0.89 BACE1 (0.48) BACE1CTSDBACE2APPSLC6A2
SCHEMBL4889010 0.88 BACE1 (0.45) BACE1CTSDBACE2APPHDAC8
SCHEMBL4882001 0.86 BACE1 (0.43) BACE1CTSDBACE2APPCHRNA1
SCHEMBL13230538 0.86 BACE1 (0.42) BACE1CTSDBACE2APPHDAC8
SCHEMBL4883739 0.85 BACE1 (0.53) BACE1CTSDBACE2APPCHRNA1
SCHEMBL8277624 0.85 BACE1 (0.46) BACE1CTSDBACE2APPSLC6A2
SCHEMBL4890662 0.85 BACE1 (0.45) BACE1CTSDBACE2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007145569-A1 AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA ASTRAZENECA AB (SE) 2007-12-21 WO disclosed